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Nuclear factor-kappa B localization and function
within intrauterine tissues from term and preterm
labor and cultured fetal membranes
Sonali Vora1, Asad Abbas2, Chong J Kim2,3,4, Taryn LS Summerfield1,5, Juan P Kusanovic2,3, Jay D Iams5,
Roberto Romero2,3, Douglas A Kniss1,5,6, William E Ackerman IV1,5*
Abstract
Background: The objective of this study was to quantify the nuclear localization and DNA binding activity of p65,
the major transactivating nuclear factor-kappa B (NF-kappaB) subunit, in full-thickness fetal membranes (FM) and
myometrium in the absence or presence of term or preterm labor.
Methods: Paired full-thickness FM and myometrial samples were collected from women in the following cohorts:
preterm no labor (PNL, N = 22), spontaneous preterm labor (PTL, N = 21), term no labor (TNL, N = 23), and
spontaneous term labor (STL, N = 21). NF-kappaB p65 localization was assessed by immunohistochemistry, and
DNA binding activity was evaluated using an enzyme-linked immunosorbent assay (ELISA)-based method.
Results: Nuclear p65 labeling was rare in amnion and chorion, irrespective of clinical context. In decidua, nuclear
p65 labeling was greater in the STL group relative to the TNL cohort, but there were no differences among the
TNL, PTL, and PNL cohorts. In myometrium, diffuse p65 nuclear labeling was significantly associated with both term
and preterm labor. There were no significant differences in ELISA-based p65 binding activity in amnion,
choriodecidual, and myometrial specimens in the absence or presence of term labor. However, parallel
experiments using cultured term fetal membranes demonstrated high levels of p65-like binding even the absence
of cytokine stimulation, suggesting that this assay may be of limited value when applied to tissue specimens.
Conclusions: These results suggest that the decidua is an important site of NF-kappaB regulation in fetal
membranes, and that mechanisms other than cytoplasmic sequestration may limit NF-kappaB activation prior to
term.
Background
The precise molecular mechanisms that underpin the
commencement of cervical effacement and dilatation,
and robust, synchronous myometrial contractions result-
ing in expulsion of the fetus at term are still incomple-
tely understood. Moreover, the untimely onset of labor
prior to 37 weeks of gestation currently contributes to a
12.5% rate of preterm deliveries culminating in signifi-
cant perinatal morbidity and mortality [1]. This actually
represents a substantial increase over estimates from
just a decade ago.
Despite the rather dismal epidemiological picture,
there is now a nearly complete consensus that sponta-
neous preterm labor is initiated by a complex set of bio-
chemical events that can be categorized as localized
inflammation resulting from the untimely activation of
the innate immune response within the intrauterine
microenvironment [2,3]. To date, the chief proximate
cause of these inflammatory sequelae is bacterial infec-
tions that colonize one or more compartments of the
female urogenital tract and/or placenta and fetal mem-
branes [4]. As further support for this notion, even sys-
temic infections remote from the gravid uterus can
incite inflammatory changes by eliciting immune activa-
tion and the release of circulating bioactive molecules
such as cytokines, chemokines, and arachidonic acid
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metabolites [5]. Many of the most common of these bio-
mediators are interleukins- 1b, 6, and 8 (IL- 1b, 6, 8),
tumor necrosis factor-a (TNF-a), macrophage chemo-
tactic peptide-1 (MCP-1), prostaglandins E2 and F2a
(PGE2 and PGF2a), and nitric oxide (NO) [6-11]. IL-1b,
IL-6 and TNF-a serve as the major immunomodulators,
while IL-8 and MCP-1 are chemokines that recruit neu-
trophils and monocytes into sites of tissue inflammation
[4]. PGE2 and PGF2a are potent bioactive lipids that sti-
mulate immune functions such as vascular reactivity
and permeability, and extracellular matrix remodeling
[12].
Interestingly, each of these events is in some way or
another governed by the canonical inflammatory tran-
scription factors, nuclear factor-kappa B (NF-B)
[13,14]. That is, this DNA-binding protein either directly
controls the genes encoding the cytokines and chemo-
kines or it controls the genes that encode the rate-limit-
ing enzymes that manufacture the mediators (PGs and
NO) [15-17]. The NF-B family of transcription factors
is made up of at least five member proteins that reach
back in evolution as far as the arthropods (e.g., fruit
flies) and they appear to regulate nearly every aspect of
modern immune responsiveness [18]. Thus, in our con-
tinuing attempts to identify the key players in the
inflammatory events that underpin one of the most fun-
damental of reproductive events, the delivery of the off-
spring, we conducted in vitro and translational in vivo
studies to link the localization and function of NF-B in
cells grown in culture (following stimulation with cyto-
kines known to be present in preterm labor) with that
in tissues collected in the absence or presence of human
parturition.
Methods
Tissue collection and study design
Tissue biopsies from clinical samples were collected
from women at the time of delivery following written
informed consent and approval from the Institutional
Review Boards (IRBs) of the Sotero del Rio Hospital,
Santiago, Chile (an affiliate of the Pontificia Catholic
University of Santiago, Chile), and the Eunice Kennedy
Shriver National Institute of Child Health and Human
Development, NIH, DHHS. Patients were classified in
the following groups: preterm no labor (PNL, N = 22),
spontaneous preterm labor (PTL, N = 21), term no
labor (TNL, N = 23), and spontaneous term labor (STL,
N = 21). Subjects delivered between gestational ages
260/0 - 366/7 weeks (preterm cohort; PNL or PTL) and
370/0 - 416/7 weeks (term cohort; TNL or STL). Paired
full-thickness fetal membrane and myometrial biopsy
samples were collected from patients who had under-
gone cesarean section for various medical conditions
(hypertension, fetal growth restriction, macrosomia), or
due to history of prior cesarean section, fetal malpresen-
tation or an unfavorable cervix by clinical examination.
Following delivery of the placenta, portions of reflected
membranes were separated into amnion and choriodeci-
dua and snap frozen in liquid N2 for subsequent analy-
sis. In parallel, full-thickness membrane rolls were fixed
in formalin in preparation for immunohistochemistry.
For the collection of myometrial specimens, biopsies of
the lower uterine segment were obtained at the time of
cesarean section by dissecting a small portion of the
uterine wall along the uterine incision prior to closure
of the uterus. Myometrial specimens were either flash
frozen in liquid N2 or fixed in formalin and paraffin
embedded for subsequent analysis.
Selected demographic characteristics of the partici-
pants are presented in Table 1. In the preterm cohort,
the PTL group tended to younger on average than the
PNL group, but the gestational ages at delivery and
birthweights were similar. In the term cohort, partici-
pants in the STL group were more likely to have been
primigravid and nulliparous, which was anticipated
given that subjects in the TNL group were more likely
to have had a prior cesarean; other characteristics were
similar. The most common indication for iatrogenic
delivery in the PNL cohort was severe preeclampsia
with abnormal Doppler velocimetry or hypertensive cri-
sis. The prevalence of preeclampsia was 73% in the PNL
cohort, compared with 5% in the PTL cohort.
Primary amnion mesenchymal cell cultures
Fetal membranes used to prepare primary amnion
mesenchymal cell (AMC) cultures were collected at the
time of delivery from women who provided written
informed consent under Biomedical IRB approval at
The Ohio State University Medical Center. Primary cul-
tures of human amnion mesenchymal cells were pre-
pared from amnion membranes stripped of underlying
chorionic tissue from placentas collected from women
prior to the onset of labor at term as previously
described [15]. Cells were cultured in high-glucose Dul-
becco’s modified Eagle’s medium (DMEM; 25 mM glu-
cose) supplemented with 10% fetal bovine serum (FBS),
2 mM L-glutamine, 1 mM sodium pyruvate, 50 μg/ml
of gentamicin sulfate, and 0.5 μg/ml of amphotericin B
at 37°C in a humidified incubator with 5% CO2. Upon
reaching confluence, cultures were then treated in the
absence or presence of 10 ng/ml of IL-1b or 20 ng/ml
of TNF-a (both from R&D Systems, Minneapolis, MN)
for 0-120 min, as described in the text and figure
legends.
Fetal membrane explant cultures
Full-thickness fetal membranes explant cultures were
established from a limited number of placentas (N = 4)
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delivered at term by elective cesarean section following
uncomplicated gestations at Hutzel Women’s Hospital
(Detroit, MI) with approval of the IRB of the Eunice
Kennedy Shriver National Institute of Child Health and
Human Development, NIH, DHHS. For each culture,
intact portions of the reflected fetal membranes between
the incision site and the placental disc were dissected
into uniform 1 in2 squares and placed in sterile PBS.
These specimens were then rinsed free of clotted blood
using sterile PBS. Full-thickness specimens, as well as
bluntly separated amniotic and choriodecidual speci-
mens, were cultured in parallel in serum-free RPMI
media in a humidified incubator at 37°C in a 5% CO2
atmosphere. Following overnight incubations, cultures
were then treated in the absence or presence of 10 ng/
ml of IL-1b for 1-2 h, as described in the text and figure
legends.
Nuclear extraction
Nuclear extraction from cultured cells was performed
using a nuclear extract kit according to the instructions
of the manufacturer (Active Motif, Carlsbad, CA). Fol-
lowing treatments, cells were suspended in hypotonic
buffer (20 mM HEPES, pH 7.5, 5 mM NaF, 10 μM
Na2MoO4, and 0.1 mM EDTA) containing phosphatase
inhibitors and incubated on ice for 15 minutes. Deter-
gent (Nonidet P-40) was added to a final concentration
of 0.5%, and incubation was continued for an additional
15 min. The lysate was then subjected to centrifugation
(14,000 × g for 30 sec at 4°C) to pellet nuclei, and the
supernatant was removed. The nuclear pellet was next
extracted in a proprietary lysis buffer for 30 min on ice
using a rotary shaker. Following centrifugation (14,000 ×
g for 30 min at 4°C), the supernatant containing the
pure nuclear fraction was collected. The concentration
of the nuclear extract was determined using the Brad-
ford Assay [19] and measured at a 595 nm absorbance
using the Dynex MLX microplate luminometer (Dynex
Technologies, Chantally, VA).
For the isolation of nuclear proteins from fetal mem-
brane explant cultures, pilot experiments were con-
ducted in which the tissues were either minced finely
and homogenized using a Dounce type homogenizer
(protocol 1), or flash frozen and ground in liquid N2
using a mortar and pestle (protocol 2), prior to extrac-
tion. In each case, extraction was performed using the
same reagents used for the cultured cells. Briefly, tissue
was incubated in hypotonic buffer on ice and extracted
using 0.5% Nonidet P-40. Following centrifugation, the
resulting pellet (presumptive nuclear fraction) was sus-
pended in a proprietary lysis buffer, and non-extracted
cellular debris was removed by centrifugation.
For the isolation of nuclear proteins from flash frozen
amnion, choriodecidua, and myometrial tissues, frozen
samples were and ground in liquid N2 using a mortar
and pestle prior to extraction using the protocol listed
above.
Transcription factor binding assay
The ELISA-based chemiluminescent NF-B p65 binding
assay kit was run according to the manufacturer’s instruc-
tions (Active Motif, Carlsbad, CA) in a 96 well-plate for-
mat. Briefly, equal amounts of nuclear extracts (2 μg for
cell culture nuclear extracts, 6-10 μg for tissue extracts,
Table 1 Selected maternal characteristics by cohort*
Preterm Cohort Term Cohort
PNL
n = 22
PTL
n = 21
P value TNL
n = 23
STL
n = 21
P value
Maternal age (y)** 27.9 ± 6.7
(16-38)
23.4 ± 7.2
(13-37)
0.0399 29.3 ± 6.3
(19-41)
26.4 ± 6.9
(16-43)
N.S.
Gestational age
at delivery (wk)**
33.1 ± 2.7
(27.3-36.3)
32.5 ± 3.0
(26.0-36.9)
N.S. 39.2 ± 1.1
(37.9-41.1)
39.5 ± 1.0
(37.6-41.1)
N.S.
Birthweight (g)** 1780 ± 520
(810-2810)
1980 ± 640
(910-3250)
N.S. 3524 ± 421
(2870-4750)
3572 ± 263
(3100-3960)
N.S.
Gravidity
1 8 9 N.S. 0 7 0.0086
2 6 5 9 4
>2 8 7 14 10
Parity
0 9 10 N.S. 1 8 0.0203
1 8 5 8 4
>1 5 6 14 9
* All specimens derived from these subjects were collected at Sotero del Rio Hospital, Santiago, Chile
** Values are given as mean ± standard deviation; the range is given in parentheses
N.S., not significant
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depending on origin) from each sample were allowed to
bind to immobilized oligonucleotides containing the con-
sensus NF-B binding sequence. In parallel reactions, sup-
plied extracts of Jurkat T lymphocytes (stimulated with
phorbol ester and calcium ionophore) were incubated as a
positive control for each assay. In some wells, competitive
binding experiments were performed by co-incubating the
nuclear extracts an excess (20 pmol) of wild-type or
mutated oligonucleotides. Samples and controls were
incubated at room temperature for 1 hr on a rotary shaker
to ensure complete binding of NF-B to its consensus
sequence. The quantity of bound p65 in each well was
detected by incubation with anti-p65 primary antibodies,
followed by horseradish peroxidase-conjugated secondary
antibodies, and the background signal (obtained by incu-
bation of reagents in the absence of nuclear extracts) was
then subtracted from all other values. Chemiluminescence
was detected using a Wallac 1420 multilabel counter (Per-
kinElmer, Shelton, CT). The lower limit of detection for
this assay was 0.5 μg of nuclear extract per well. The intra-
assay coefficient of variation was <10%, while the inter-
assay coefficient of variation ranged from 10-20%. Due to
the large between-assay variation, all samples used for
direct statistical comparison were run in the same assay.
Immunofluorescence
Amnion mesenchymal cells were plated onto sterile
glass coverslips placed in 4-well tissue culture plates and
treated with either IL-1b (10 ng/ml) or TNF-a (20 ng/
ml) for 5, 15, 30, 60 and 120 min. Control cells were
treated with serum-free medium only. Following each
treatment, cells were washed and fixed in 4% parafor-
maldehyde/PBS solution for 1 h, permeabilized with a
0.2% Triton X-100/PBS solution for 15 min, and
blocked in 5% normal goat serum/PBS solution for 1 h.
Antibodies directed against NF-B p65 were applied
overnight at 4°C. After washing in PBS, coverslips were
exposed to fluorochrome-conjugated secondary antibo-
dies for 1 h at room temperature. Coverslips were then
mounted using the ProLong gold antifade reagent with
4’,6-diamidino-2-phenylindole (DAPI; Molecular Probes/
Invitrogen, Carlsbad, CA) and visualized using an epi-
fluorescence microscope (Zeiss Axiovert 200 M).
To assess the extent of nuclear p65 immunolabeling in
the AMC cultures, digital images were acquired from 10
randomly selected, non-overlapping fields from each
treatment group. The p65 nuclear labeling index (NLI,
defined as the ratio of the number of p65-immunola-
beled nuclei divided by the total number of nuclei) was
then calculated for each time point.
Immunohistochemistry (IHC)
Tissues fixed in 10% neutral-buffered formalin were
dehydrated and embedded in paraffin. Standard paraffin
sections (5 μm) of full-thickness fetal membranes rolls
and myometrial biopsies were deparaffinized in xylene
and rehydrated through graded ethanol. Immunostaining
was performed on using a Discovery autostainer (Ven-
tana Medical Systems Inc., Tucson, AZ). Following anti-
gen retrieval in citrate buffer (pH 6.0), the sections were
incubated with 1:1,000-diluted rabbit polyclonal anti-
human NF-B p65 antibody (ab7970, Abcam, Cam-
bridge, MA) for 1 h. Pre-diluted biotinylated universal
anti-rabbit/mouse IgG (Ventana Medical Systems Inc.,
Tucson, AZ) was used as a secondary antibody, and a
DAB MAP kit (Ventana Medical Systems Inc., Tucson,
AZ, USA) was used for the chromogen reaction. Coun-
ter staining was performed with Mayer’s hematoxylin.
The specificity controls used were a polyclonal rabbit
immunoglobulin preparation (product no. 08-6199;
Zymed/Invitrogen, Carlsbad, CA) and primary antibody
omission control. Additional immunolabeling was per-
formed using primary antibodies raised against p65
phosphorylated at serine 276 (ab2615, Abcam) and p65
phosphorylated at serine 536 (antibody #3031, Cell Sig-
naling Technology, Danvers, MA); however, despite sev-
eral attempts using a range of titers and antigen-
retrieval conditions, we were unable to detect immuno-
labeling that was distinct from that of controls using
these reagents.
A systematic assessment of nuclear p65 immunolabel-
ing in fetal membranes and maternal decidua was per-
formed using a targeted strategy. To this end, an “X”
was lightly outlined over each fixed full-thickness fetal
membrane roll, and for each specimen, five points of
intersection between the “X” and the membrane roll
were selected for imaging. Color digital micrographs
were obtained using a coded scheme and subsequently
analyzed independently by two blinded observers (S.V.
and A.A.). The NLI (described above) was then calcu-
lated for each image in the amnion, chorion, and decid-
ual layers. The total NLI was calculated as the total
number of p65 labeled nuclei in each of the five micro-
graphs for a given layer divided by the total number of
nuclei in that layer. Discrepancies were resolved by rea-
nalysis by a single blinded observer (W.E.A.).
For the assessment of the extent of nuclear p65
immunolabeling in myocytes within myometrial biopsy
specimens, nuclear p65 immunolabeling was assessed by
a single blinded observer (C.J.K.) using a graded scale:
no nuclear p65 immunoreactivity (-); isolated nuclear
p65 immunoreactivity in a minority of myometrial cells
(+); and diffuse nuclear p65 immunoreactivity in a
majority of myometrial cells (++).
Statistical analysis
Statistical analyses were performed using Stata/IC ver-
sion 10.0 (StataCorp, College Station, TX) and
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GraphPad Prism version 5.01 (GraphPad Software, La
Jolla, CA) software packages. The Shapiro-Wilk test for
normality was initially performed on all variables under
consideration (demographic data, nuclear labeling
indices, and p65 binding activities) to determine
whether parametric statistical testing would be valid in
each instance. One-way ANOVA was used to compare
fetal membrane NLIs in each clinical cohort. For pair-
wise comparisons of DNA binding activity (e.g., between
treated and untreated groups in explants cultures), Stu-
dent’s t-test was employed. For myometrial specimens,
the proportions of cases from each cohort exhibiting
absent, isolated, or diffuse nuclear p65 immunoreactivity
were compared using the Chi-square test. To compare
demographic and clinical characteristics between sub-
groups of the term and preterm cohorts, Student’s t-test
was also used for parametric continuous variables
(maternal age, gestational age at delivery, and birth-
weight), and Fisher’s exact test was used for categorical
variables (gravidity and parity).
Results
Cytokine stimulation elicits cytoplasmic-to-nuclear
translocation of NF-B p65 in AMC cultures
Studies in our laboratory and by other groups, using
many cell culture models, have shown that stimulation
with one of many proinflammatory cytokines or bacter-
ial products (e.g., IL-1b, TNF-a, or lipopolysaccharide)
promotes the rapid translocation of NF-B from the
cytoplasm into the nucleus, where it acts as a critical
transcription factor driving inflammation. In the present
work, we examined whether cytokines found in amniotic
fluid from women in preterm or term labor could acti-
vate cytoplasmic-to-nuclear translocation of the tran-
scriptionally active NF-B p65 protein subunit in
amnion mesenchymal cells grown in vitro. Following
treatment with either IL-1b (10 ng/ml) or TNF-a (20
ng/ml), there was a time-dependent increase in the loss
of cytoplasmic p65 immunoreactivity and a subsequent
increase in the accumulation of p65 in the nucleus (Fig.
1A). By calculating the p65 NLI, we observed that maxi-
mal levels of nuclear p65 immunoreactivity were
reached 30 min after treatment and remained elevated
through 120 min (Fig. 1B). Cells treated with medium
alone during this time did not exhibit nuclear accumula-
tion of p65 (data not shown).
Cytokine treatment induces specific binding to the B
oligonucleotide sequence in AMC cultures
We next determined whether cytokine exposure of
AMCs could induce the specific binding of cellular pro-
teins to the consensus B binding element using an
ELISA-based assay system. Like the electrophoretic
mobility shift assay (EMSA), this assay detects specific
DNA-protein interactions, but is designed to enable
high throughput and straightforward quantification.
Cells were grown for 2 days in vitro and the challenged
with IL-1b (10 ng/ml) or TNF-a (20 ng/ml) for 30 min
followed by nuclear extraction. Nuclear extracts were
incubated with the B oligonucleotide in solid-phase,
and the amount specific binding of p65 to the B bind-
ing motif was detected using an antibody and chemilu-
minescence. We observed a robust increase in binding
following either IL-1b challenge (ranging from 5-fold to
33-fold in 4 experiments) and TNF-a stimulation (ran-
ging from 4-fold to 21-fold in 4 experiments), compared
to medium-treated control cells (Fig. 1C). Specificity
controls revealed that this binding activity could be
blocked using an excess of soluble oligonucleotides
bearing the B motif, but not with oligonucleotides
bearing the same sequence when scrambled. These
results, when combined with the nuclear translocation
experiments, indicate that cytokine stimulation leads to
the accumulation of nuclear NF-B which is capable of
specific DNA-binding to the B element.
NF-B p65 DNA binding activity in fetal membrane
explants and tissues
Having established that p65 nuclear localization corre-
sponded with its DNA binding activity in AMC cultures,
we next sought to extend these results to the more
complex scenario of fetal membrane explants. In pilot
experiments, we found that p65 DNA binding activity
could be recovered at similar levels using either homo-
genization of unfrozen tissues, or following flash-freez-
ing prior to nuclear extraction. We found that the p65
binding activity was unexpectedly high in unstimulated
tissues when compared with untreated AMCs (compare
untreated amnion and choriodecidua in Fig. 2 with
untreated AMCs in Fig. 1C). In the amnion, there was
no increase in binding activity following stimulation
with IL-1b for 2 h. While a modest 1.4-fold increase in
p65 binding activity was observed in the choriodecidua
following IL-1b challenge, this was an order of magni-
tude less than the increase observed in IL-1b treated
AMC extracts, and was not statistically significant.
We next attempted to apply the ELISA-based p65
binding assay to a subset (N = 10/group) of flash-frozen
tissue samples (amnion, choriodecidua, and myome-
trium) in the absence or presence of term labor. In con-
trast to the results obtained in our IHC analysis (below),
we observed no significant differences in p65 binding
activity between the TNL and STL groups for any of the
tissues examined (Additional File 1: Figure S1). In addi-
tion to these experiments, a subset (N = 4) of preterm
amnion and choriodecidual specimens were analyzed for
p65 binding activity. When these were compared with
the binding activities recovered from amnion and
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choriodecidual samples of the TNL and STL groups, no
significant differences were observed (not shown). How-
ever, the binding activity in all cases appeared to be spe-
cific, since it could be suppressed using an excess of
unbound oligonucleotides containing the B binding
motif, but not with oligonucleotides harboring the same
sequence when scrambled (Additional File 1: Figure S1).
Based on these negative results, we opted not to extend
these studies to the remaining tissues collected from
these cohorts.
Immunohistochemical localization of NF-B p65 in
intrauterine tissues in term and preterm parturition
Inasmuch as we were unable to reliably quantify the
extent of DNA binding activity of nuclear p65 within
frozen tissue samples, a surrogate approach was adopted
in which the degree of nuclear p65 immunostaining was
evaluated in the fetal membranes, decidua, and myome-
trium. Such an approach has been employed previously
in clinicopathologic studies [20-22] to assess the poten-
tial for p65 transactivation based on its cytoplasmic-to-
Figure 1 Correlation between nuclear translocation and DNA binding of NF-B p65 in AMC cultures. (A) Intracellular localization of the
p65 subunit of NF-B as detected by immunofluorescence in primary cultures of AMCs treated with 10 ng/ml of IL-1b or 20 ng/ml of TNF-a for
5-120 min. Arrows indicate prominent p65 immunolabeling in cell nuclei, while arrowheads indicate nuclei with deficient p65 labeling. Control
cultures exhibited labeling similar to that shown for the 5 min time points (not shown). Bars = 20 μm. (B) Graphical representation of the p65
NLI, depicted as the percent of nuclei with prominent p65 labeling, in AMCs following cytokine stimulation. For each time point, p65 labeling in
a minimum of 100 nuclei were enumerated from 10 randomly selected, non-overlapping microscopic fields. (C) DNA binding activity of NF-B
p65 as assessed in nuclear extracts (2 μg/well) of AMCs treated for 30 min with medium alone (untreated control), 10 ng/ml of IL-1b, or 20 ng/
ml of TNF-a using an ELISA-based chemiluminescent assay (mean ± SD, N = 3 replicates in a single experiment that is representative of 4
identical experiments obtained using three separate AMC preparations). Values from the luminometer are expressed as relative light units (RLU).
As a control for assay specificity, Jurkat T lymphocyte extracts were incubated in the absence (pos. control) or presence of an excess of unbound
oligonucleotides bearing either the consensus (B oligo) or mutated (mut. oligo) NF-B binding motif.
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nuclear translocation within tissue specimens, including
fetal membranes [23].
We found that, with the exception of rare instances
(Fig. 3B), nuclear p65 immunolabeling was essentially
absent in the amnion and chorion layers, irrespective of
clinical context (Fig. 3A). These results were unchanged
when we extended our analysis beyond the five photo-
micrographs targeted for NLI quantification, suggesting
that our findings were applicable to the entire fetal-
membrane tissues available for analysis. In contrast to
the amniochorion, p65 labeling was prominent in decid-
ual layers in all specimens examined. Analysis of the
p65 NLI in the decidua revealed that the median NLI
was 39.4% TNL cohort (Fig. 3C). Relative to the TNL
cohort, the p65 decidual NLI in the TIL group (median:
55.9%) was significantly increased (p < 0.05). The med-
ian decidual p65 NLI in the PTL cohort was similar to
that of the term labor group (54.7%). Unexpectedly, pro-
nounced nuclear p65 labeling (median: 57.7%) was
observed in the PNL group.
In the myometrium, diffuse p65 nuclear labeling (++)
in myocytes was observed only in the PTL and STL
groups, representing 26% and 50% of cases, respectively
(Fig. 4, P < 0.001); no diffuse p65 immunolabeling was
observed in the unlabored groups. Correspondingly, the
proportion of cases with negative (-) nuclear p65 immu-
nolabeling decreased following preterm or tem labor.
While the proportion of cases exhibiting sporadic (+)
nuclear p65 labeling was similar between the PNL, PTL,
and PNL cohorts (33% to 36%) this proportion was rela-
tively increased in the TNL group (57%).
Discussion
There is compelling evidence that term and preterm
labor are both associated with localized inflammatory
responses. As an example, transcriptional profiling has
recently demonstrated upregulation in a panoply of
immune response genes within full-thickness fetal mem-
branes following spontaneous term parturition [24].
Microarray studies have further suggested that global
increases in inflammatory gene expression are more
pronounced in the setting of preterm labor, particularly
when complicated by intrauterine infection [7]. The NF-
B transcription factors, which govern the regulation of
a number of immune response genes, are now thought
to play a central role in human labor (see references 25-
28 for recent reviews). While highly plausible, the evi-
dence for intrauterine NF-B activation in term human
labor is, in large part, extrapolated from studies using
cell cultures in vitro. To date, studies of NF-B activa-
tion in tissue specimens have produced inconsistent
results. Such inconsistencies provided motivation for the
current study, which was developed as a more compre-
hensive analysis of intrauterine NF-B activation within
intrauterine tissues in the settings of spontaneous pre-
term and term labor.
Using immunohistochemical analysis, we found that
nuclear localization of the p65 NF-B subunit was
essentially absent in the amniochorion, regardless of
labor status. While comparable findings have been pre-
sented previously [23], these results are in direct conflict
with evidence of p65 binding activity based on biochem-
ical analyses of these same tissues. For instance, in pre-
and post-labor cultures of amnion cells, EMSA revealed
apparent increases in the binding of the p65 and p50
NF-B subunits to cognate response elements following
term labor [29,30]. Similarly, using ELISA-based DNA
binding assays, Lappas and Rice have reported that term
labor was associated with increased p65 activity in the
amnion (but not the choriodecidua) following term
labor [27]. In addition, using chromatin immunoprecipi-
tation (ChIP), Mitchell et al. found that p65 binding to
the NF-B responsive IBa gene promoter (but not the
cyclooxygenase-2 promoter) increased in the amnion
following term labor [31]. In contrast with these prior
reports, we were unable to document biochemical evi-
dence of increased p65 binding activity in either the
amniotic or the choriodecidual tissues following term
labor.
Figure 2 DNA binding of NF-B p65 in fetal membrane explant
cultures. Nuclear protein extracts from amnion (10 μg/well) and
choriodecidua (6 μg/well) explants incubated in the absence or
presence of 10 ng/ml of IL-1b for 2 h were analyzed for NF-B p65
binding activity using an ELISA-based chemiluminescent assay
(mean ± SD, N = 4 explants). Values from the luminometer are
expressed as relative light units (RLU). Specificity controls were
conducted using Jurkat T lymphocyte extracts incubated in the
absence (pos. control) or presence of an excess of unbound
oligonucleotides bearing either the consensus (B oligo) or mutated
(mut. oligo) NF-B binding motif; similar results were obtained
when amnion or choriodecidual lysates were incubated with these
oligonucleotides (not shown). Relative to the untreated explants,
explants stimulated with IL-1b did not show significant increases in
p65 binding activity.
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We have considered that incongruities between the
IHC and biochemical results may reflect inherent limita-
tions in one or both of these assays when applied to tis-
sue specimens. Notably, we observed unexpectedly high
levels of presumptive p65 DNA binding in amnion,
choriodecidua, and full-thickness fetal membrane
explants, even in the absence of stimulation. These
results are in sharp contrast to those obtained when the
same assay was applied to primary cultures of amnion
mesenchymal cells, in which there was good agreement
between the binding assay and immunolabeling results.
Inasmuch as the binding activity from tissue extracts
could be competitively diminished using an excess of
unbound oligonucleotides containing B binding ele-
ments (but not with oligonucleotides harboring the
same sequence when scrambled), and also required p65-
like immunoreactivity for detection, there is little reason
to believe that such results were due to nonspecific
interference with the DNA binding assays. A more likely
explanation is that, unlike the cultured cells, enrichment
Figure 3 Immunohistochemical localization of NF-B p65 in term and preterm fetal membranes and decidua. (A) Representative
photomicrograph demonstrating characteristic p65 immunolabeling. In almost all cases, nuclear p65 labeling was absent in the amnion (Amn)
and chorion (Chor), but prominent in the decidua (Dec). (B) Foci of nuclear p65 labeling were exceedingly rare in the amnion and absent in the
chorion among all tissues examined. In both panels, arrows indicate areas of with nuclear p65 immunolabeling, while arrowheads demonstrate
nuclei with deficient p65 labeling. Bars = 100 μm. (C) Box-and-whiskers plot of the p65 NLI in decidua from the following cohorts: preterm no
labor (PNL, N = 22), spontaneous preterm labor (PTL, N = 21), term no labor (TNL, N = 23), and spontaneous term labor (STL, N = 21). NLI was
calculated from a total of five micrographs per case, as selected using the targeted strategy described in the Methods section. The NLI in the
TNL group was significantly less than that in the STL group (* P < 0.05, one-way ANOVA with Tukey’s multiple comparison post hoc test).
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for nuclear p65-containing NF-B complexes was
incomplete during the isolation of nuclei from tissues;
thus, significant interference may have resulted from co-
extraction of an excess of p65 from extranuclear sources
when explants or frozen tissue samples were used. On
the other hand, given that a greater amount of tissue
was available for query by biochemical analysis relative
to IHC, it is also possible that under-sampling may have
contributed to an erroneously low estimate of the extent
of p65 nuclear labeling by immunolabeling. However,
this seems unlikely, given that nuclear p65 labeling was
consistently absent in nearly all of the 87 fetal mem-
brane micrographs available for examination.
Unlike the amniochorion, decidual p65 nuclear immu-
nolabeling was evident in all specimens examined. Con-
sistent with numerous reports of increased NF-B
responsive genes in fetal membranes following term
labor [5,7,24,25,28], we observed that the decidual p65
NLI was significantly higher in the STL cohort relative
to the TNL group. However, since the median decidual
p65 NLI was still approximately 40% in TNL specimens,
these results also suggest that a lesser degree of NF-B
activity may exist prior to the onset of term labor. Such
activity could partially explain the observation that a
subset of immune response genes are expressed at high
levels in term, unlabored fetal membrane specimens
[24].
Unexpectedly, we observed substantial levels of decid-
ual nuclear p65 labeling in both of the preterm cohorts,
irrespective of labor status. These results differ from
those of Yan and colleagues, who observed a significant
increase in the nuclear staining of p65 in term decidua
compared to tissues obtained following preterm labor
[23]. While p65 nuclear localization is an imperfect sur-
rogate for NF-B transactivation, our IHC results sug-
gest that decidual cells possess some potential for tonic
NF-B activity; however, considering that such labeling
can occur in the absence of preterm labor (as was
observed in the PNL group), the significance of this
observation may differ from that in the term setting.
This could potentially be due to underlying occult
inflammation within decidual tissues isolated from pre-
term, apparently “control” specimens. In addition, it is
plausible that other nuclear receptors, such as isoforms
of the progesterone receptor [28,32] and peroxisome
proliferator-activated receptors (PPARs) [27], contribute
to the repression of fulminant NF-B transactivation in
the decidua during the bulk of gestation. Alternatively,
given the high prevalence of preeclampsia in the PNL
group, we considered that an amplified immune
response within specimens delivered of preeclamptic
mothers might have skewed our results; however, when
the decidual NLI was stratified based on absence or pre-
sence of preeclampsia, the labeling indices in each
Figure 4 Immunohistochemical localization of NF-B p65 in
term and preterm myometrium. (A-C) Representative
photomicrographs demonstrating the graded scale used to semi-
quantitatively assess the extent of p65 immunolabeling in myocytes:
(A) no nuclear p65 immunoreactivity (-); (B) isolated nuclear p65
immunoreactivity in a minority of myometrial cells (+); (C) diffuse
nuclear p65 immunoreactivity in a majority of myometrial cells (++).
The arrows indicate typical myocytes with nuclear p65
immunolabeling. Bars = 100 μm. (D) Percentage of cases with
absent, isolated, and diffuse nuclear p65 staining in myometrial
myocytes from biopsy specimens obtained from the following
cohorts: preterm no labor (PNL, N = 21), spontaneous preterm labor
(PTL, N = 21), term no labor (TNL, N = 23), and spontaneous term
labor (STL, N = 21). There were significantly greater proportions of
cases exhibiting diffuse nuclear p65 immunolabeling in the PTL and
STL groups relative to the unlabored cohorts (P < 0.001, Chi-square
test).
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subgroup did not differ significantly from one another,
nor from the PTL group (results not shown).
Another possibility for the observed high levels of
nuclear NF-B in non-laboring tissues lies within the
heretofore unappreciated biological complexity of the
NF-B transcription pathway, especially with regard to
the inhibitor proteins collectively known as IB. Most
studies reported to date in the context of parturition
have dealt with the NF-B and IB system as something
of a binary switch between an active, free NF-B inflam-
matory transcription factor and the NF-B: IB complex
that is transcriptionally silent and sequestered in the
cytoplasm [26]. This is an oversimplification. Rather
than a simple schema in which NF-B resides entirely
in the cytoplasm under resting conditions, and is then
rapidly transported to the nucleus following proinflam-
matory stimulation, recent studies have demonstrated
that p65 complexed to other NF-B subunits shuttles in
and out of the nucleus in an oscillatory pattern [33-35].
Using mathematical modeling, it has been predicted that
at any one instant in time, NF-B could indeed be loca-
lized in the nucleus, even in the absence of cell stimula-
tion and, this could be due in part to the complexity of
the IB inhibitors and cell to cell variability [36,37].
Thus, it is highly possible that, during the collection of
tissue specimens in both the pre-laboring and post-
laboring conditions, immunostaining in one or more tis-
sues could localize p65 within the nuclear compartment,
even in the absence of inflammation (i.e., signals herald-
ing labor). These oscillations could also be translated
into the finding of elevated DNA binding events even
under resting conditions. Therefore, when attempting to
consider the global role of NF-B in regulating parturi-
tion in human tissue specimens, some caution is
warranted.
In the myometrium, we observed no diffuse nuclear
p65 labeling in myometrial cells collected in the absence
of preterm or term labor. In comparison, the proportion
of cases with diffuse p65 labeling increased following
both preterm and term labor, suggesting: (1) that promi-
nent p65 labeling in the decidua can exist without
apparent extension to the myometrium (as is evident in
paired specimens collected in the PNL cohort); (2) that
diffuse nuclear p65 labeling in myometrial smooth mus-
cle cells is specifically associated with labor (indicating
that such labeling may correspond with increased NF-
B transcriptional activity); and (3) that labor can occur
in the absence of diffuse myometrial p65 labeling, at
least in the regions we studied. Regarding the latter
point, it is to be noted that all of the specimens available
for our analysis were sampled from the lower uterine
segment; therefore, we were unable to examine p65
labeling in the uterine fundus. Condon et al., using
nuclear and cytosolic extracts collected from a small
number of samples from the lower uterine segment and
fundal myometrium, observed a pronounced increase in
nuclear levels of p65 following term labor only in the
fundus [38]. In contrast, Chapman et al. reported low
levels of p65 NF-B DNA binding activity in the lower
uterine segment using EMSA and supershift assays [39].
We speculate that diffuse p65 nuclear labeling might
have been observed in a greater proportion of post-labor
cases had the fundal portion of the myometrium been
available for analysis. Nevertheless, given the relatively
large number of samples used in the current study, we
observed that a proportion of cases (~25% in the pre-
term cohort, and ~50% in the term cohort) exhibited
potential for increased NF-B transactivation in the
lower uterine segment following labor. In this setting,
NF-B activation may promote uterine contractility via
upregulation of contraction-associated genes, such as
cyclooxygenase-2, oxytocin receptor, and connexin 43
[28].
Strengths of the current study include its size, as well as
the availability of paired myometrial and full-thickness
fetal membrane specimens for analysis of p65 immunolo-
calization. While we intended to supplement these results
with quantification of NF-B DNA binding capacity in
each sample, as we progressed from cells to explant cul-
tures to tissues, we became less confident in the ability of
the assay to accurately reflect physiologically relevant
changes in p65 activity. Nevertheless, we believe that the
systematic approach presented here illustrates the poten-
tial limitations of DNA binding assays when applied to
complex tissues. In future studies, the use of a surrogate
approach, such as ChIP analysis (which, in theory, should
provide a sensitive index of transcription factor binding in
the context of specific gene promoters without the need
for stringency in nuclear isolation), might be of greater
value. Like all studies that rely on the collection of tissues
post-delivery, we were limited in the availability of time
points for sampling, and were unable to follow changes
longitudinally in a given subject. As such, it is possible
that transient changes in p65 nuclear localization, as
might occur just prior to labor or only in its earliest stages,
might have been missed. Furthermore, it is known that
p65 is the target of a number of posttranslational modifi-
cations, such as phosphorylation and acetylation, which
serve to modulate its transactivation potential [40].
Although it would have been of interest to study such
modifications in greater detail, attempts to utilize antibo-
dies directed against post-translationally modified p65
were unsuccessful.
In conclusion, the current results suggest that the
decidua is an important site of NF-B regulation in the
fetal membranes during the latter part of gestation.
Inasmuch as prominent nuclear p65 labeling was
observed in the absence of labor or apparent extension
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to the myometrium, we speculate that mechanisms
other than cytoplasmic sequestration must exist to limit
fulminant transcriptional activation of NF-B-responsive
genes prior to term.
Additional file 1: Supplemental Figure 1: Effect of labor status at
term on NF-B p65 DNA binding activity. (A-C) Nuclear protein
extracts from amnion (A), choriodecidua (B), and myomterium (C)
collected from women before and after term labor and analyzed for NF-
B p65 DNA binding activity using an ELISA-based chemiluminescent
assay (mean ± SD, N = 10 tissues/cohort). Values from the luminometer
are expressed as relative light units (RLU). There were no statistically
significant differences observed between the TNL and STL groups. (D-E)
Specificity controls were conducted using amnion, choriodecidua (CD),
or myometrial extracts incubated in the absence (no oligo) or presence
of an excess of unbound oligonucleotides bearing either the consensus
(B oligo) or mutated (mut. oligo) NF-B binding motif (mean ± SD of
three technical replicates in a single assay).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1477-7827-8-8-
S1.EPS ]
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